#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma recurrent Immunodeficiency Brain abscess Testicular leiomyosarcoma Paraneoplastic neurological syndrome Fms-like tyrosine kinase 3 positive Marginal zone lymphoma recurrent Congenital generalised lipodystrophy Subdural haematoma Malignant fibrous histiocytoma Carcinoid syndrome Primary biliary cholangitis Rhabdomyosarcoma recurrent Chemical burn Gaucher's disease type III More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Treatment Bronchiolitis obliterans syndrome – Basic Information Anaplastic thyroid cancer – Treatment Choroid melanoma – Diagnostics VEXAS syndrome – Basic Information Hereditary angioedema – Treatment Hereditary hypophosphataemic rickets – Basic Information Glomerulonephritis rapidly progressive – Basic Information Carcinoid syndrome – Diagnostics Richter’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    7-Ethyl-10-Hydroxycamptothecin Gadobutrol Mometasone Furoate Ph. Eur. Etripamil Tepotinib Gskvx000000008866 Acetylsalicylic Acid Ph. Eur. Morphine Sulfate Co-Trimoxazole HUMAN FIBROBLASTS Bosutinib Iclepertin Ecoo75 CHOLINE ALFOSCERATE A3907 Kd050 Bgb-15025 Citrate PETHIDINE HYDROCHLORIDE A52 Clemastine Fumarate More therapies…

    Learn about Your Condition

    Renal impairment Cholecystitis acute Osteomyelitis Osteogenesis imperfecta Acute on chronic liver failure Dizziness Papillary thyroid cancer Actinic keratosis Osteochondrodysplasia Post-traumatic headache Juvenile absence epilepsy Acute myeloid leukaemia Haemorrhage Lung adenocarcinoma stage III Phenylketonuria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Role of Vitamin D (Colecalciferol) in Preventing Graft-Versus-Host Disease in Patients Undergoing Stem Cell Transplantation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Blood disorder
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study on Rituximab, Tocilizumab, and Tofacitinib for Patients with Granulomatosis with Polyangiitis Not Responding to Standard Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Azathioprine
    • Methotrexate
    • Mycophenolate Mofetil
    France

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Carfilzomib
    • Dexamethasone
    Belgium France

  • Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaemia of chronic disease
    Investigated Drugs:
    • Darbepoetin Alfa
    • Efepoetin Alfa
    Bulgaria Czechia Hungary Italy Poland

  • Study on Dasatinib for Preventing Side Effects in Patients with Relapsed or Refractory Multiple Myeloma Receiving Idecabtagene Vicleucel Therapy

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Cytokine release syndrome
    Investigated Drugs:
    • Dasatinib
    • Idecabtagene Vicleucel
    Germany

  • Study on CCTx-001, Cyclophosphamide Monohydrate, and Fludarabine Phosphate for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia recurrent
    • Acute myeloid leukaemia refractory
    Investigated Drugs:
    • Cctx-001
    • Cyclophosphamide Monohydrate
    • Fludarabine Phosphate
    France Germany Spain Sweden
Previous Page
1 … 42 43 44 45 46 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!